BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17216532)

  • 1. The contribution of Gianni Bonadonna to the history of chemotherapy.
    Ribatti D
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):309-12. PubMed ID: 17216532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of solid tumors: an American-Italian collaboration: a celebration of the work of Gianni Bonadonna.
    DeVita VT; Canellos GP
    Tumori; 2016; 102(2):124-6. PubMed ID: 27002947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
    Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
    Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcomes in studies of advanced Hodgkin's lymphoma.
    Johnson PW; Radford JA; Cullen MH; Sydes MR; Stenning SP; Hancock BW
    J Clin Oncol; 2006 Jul; 24(20):3309; author reply 3309-10. PubMed ID: 16829655
    [No Abstract]   [Full Text] [Related]  

  • 5. Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data?
    Basaran G; Agaoglu F; Basaran M
    J Clin Oncol; 2010 Sep; 28(27):e485-6; author reply e487. PubMed ID: 20606082
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of metastatic breast cancer].
    Yahalom J; Biran S; Sulkes A
    Harefuah; 1986 Jul; 111(1-2):8-11. PubMed ID: 2430868
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy for Hodgkin's disease.
    Ekert H
    N Engl J Med; 2003 Sep; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary cutaneous Hodgkin's lymphoma.
    Mukesh M; Shuttleworth D; Murray P
    Clin Exp Dermatol; 2009 Dec; 34(8):e673-5. PubMed ID: 19817768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternating drug combinations for advanced Hodgkin's disease.
    N Engl J Med; 1982 Sep; 307(11):687-9. PubMed ID: 6180317
    [No Abstract]   [Full Text] [Related]  

  • 10. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R; Nomdedeu J; Brunet S
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract]   [Full Text] [Related]  

  • 11. Hodgkin's disease presenting with osseous involvement.
    Chandra D; Ewton A; Baker K
    Am J Hematol; 2006 Jul; 81(7):550-1. PubMed ID: 16755566
    [No Abstract]   [Full Text] [Related]  

  • 12. [Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Suon SZ
    Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):117-120, contd. PubMed ID: 2580675
    [No Abstract]   [Full Text] [Related]  

  • 13. Corticosteroid drugs: their role in oncological practice.
    Lowenthal RM; Jestrimski KW
    Med J Aust; 1986 Jan; 144(2):81-5. PubMed ID: 2417096
    [No Abstract]   [Full Text] [Related]  

  • 14. Uncommon presentations of Hodgkin's disease. Case 3. Hodgkin's disease: rectal presentation.
    Simpson L; Taylor S; Piotrowski A
    J Clin Oncol; 2004 Jan; 22(1):196-8. PubMed ID: 14701784
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term follow-up of survival in Hodgkin's lymphoma.
    Canellos GP; Niedzwiecki D; Johnson JL
    N Engl J Med; 2009 Dec; 361(24):2390-1. PubMed ID: 20007568
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rescue treatment in Hodgkin's disease].
    Zori Comba A; Koziner B
    Sangre (Barc); 1987; 32(1):67-76. PubMed ID: 2438788
    [No Abstract]   [Full Text] [Related]  

  • 17. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 18. The cure of Hodgkin's disease with drugs.
    DeVita VT; Hubbard SM; Moxley JH
    Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Subbiah V
    N Engl J Med; 2008 Feb; 358(7):743; author reply 743. PubMed ID: 18283721
    [No Abstract]   [Full Text] [Related]  

  • 20. Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy.
    Specht L
    Cancer Treat Rev; 2004 Aug; 30(5):479-82. PubMed ID: 15245780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.